The store will not work correctly when cookies are disabled.
US9163007, 32
ID: ALA3968307
PubChem CID: 25166658
Max Phase: Preclinical
Molecular Formula: C16H11Cl2N5
Molecular Weight: 344.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(Cl)c1
Standard InChI: InChI=1S/C16H11Cl2N5/c17-13-3-1-11(14(18)6-13)8-23-9-16(21-22-23)10-2-4-15-12(5-10)7-19-20-15/h1-7,9H,8H2,(H,19,20)
Standard InChI Key: RCVRAKKZOKHPFT-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
9.7737 -6.4739 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.0732 -5.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5807 -5.6488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7051 -4.4308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3221 -3.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4437 -1.8466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9531 -1.9978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9511 -0.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7343 -2.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2010 -3.2956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 1.2135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6065 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 -1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8147 -2.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3084 -1.8206 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.6903 -4.1323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 1 0
19 20 2 0
20 12 1 0
5 21 1 0
21 22 1 0
21 23 2 0
23 2 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.21 | Molecular Weight (Monoisotopic): 343.0392 | AlogP: 4.18 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.43 | CX Basic pKa: 1.65 | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.61 | Np Likeness Score: -2.31 |
References
1. (2015) 5-substituted indazoles as kinase inhibitors, |